GSK PLC-SPON ADR (GSK) Stock Institutional Owners
GSK PLC-SPON ADR (GSK) is held by 8 institutional investors with a total value of $3.46B. This comprehensive analysis highlights the top institutional holders led by Dodge & Cox Stock Fund, Renaissance Technologies LLC, Kahn Brothers Group, and others, who collectively account for nearly 100% of the total institutional ownership.Dodge & Cox Stock Fund remains the largest institutional holder with a position worth $3.38B. Explore insights into ownership patterns, position sizes, and portfolio allocations to understand institutional investment strategies and market sentiment.
Explore more:
- GSK PLC-SPON ADR (GSK) stock institutional trading activity
- GSK PLC-SPON ADR (GSK) stock insider trading activity
- Stock rankings
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance |
|---|---|---|---|---|
| Dodge & Cox Stock Fund | V. D. Dodge, E. M. Cox | 1.83% | 78,403,734 | $3,383,905,159 |
| Renaissance Technologies LLC | Jim Simons | 0.08% | 1,035,572 | $50,784,451 |
| Kahn Brothers Group | Thomas Graham, Alan, Irving Kahns | 1.55% | 178,696 | $8,763,251 |
| Hillman Value Fund | Mark A. Hillman | 3.56% | 141,779 | $6,119,182 |
| Tweedy, Browne Co All Funds (US) | B. Tweedy, Ch. Browne | 0.33% | 82,243 | $4,033,197 |
| Causeway Capital Management | Sarah Ketterer | 0.02% | 33,897 | $1,662,321 |
| Sequoia Financial Advisors | 0.01% | 32,674 | $1,410,214 | |
| Hancock Classic Value | Richard Pzena | 0.00% | 13,444 | $659,292 |
Frequently asked questions about GSK
Who owns the most GSK stock?
The largest holders of GSK are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for GSK PLC-SPON ADR (GSK).
Is GSK widely held by superinvestors?
Many widely followed stocks like GSK appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly GSK is represented among the institutional managers we track.